[ad_1]
(Boursier.com) — After falling by more than 5% at midday,Sartorius Stedim Biotech limits its decline to less than 1.2% at 179.6 euros. Its parent company, Sartorius, is participating in the Bank of America Global Healthcare conference in London. A spokesperson for the German group confirmed to Bloomberg that the company will be at the conference, adding that there is “no news today from our side on the conference, just a reiteration of what we said” on a call in late July. The spokesperson highlighted the volatility of the stock price in recent weeks, as well as the “generally bearish outlook from brokers for the entire bioprocessing sector.”
©2024 Boursier.com
[ad_2]
Source link -87